TRCT
ONCR

Tower Research Capital (TRC)’s Oncorus, Inc. ONCR Stock Holding History

Tower Research Capital (TRC)’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,581
Closed -$3K – 6525
2023
Q1 		$3K Sell
8,581
-21
-0.2% -$8 ﹤0.01% 5289
2022
Q4 		$2K Sell
8,602
-2,555
-23% -$1.45K ﹤0.01% 5496
2022
Q3 		$9K Buy
11,157
+2,855
+34% +$3.66K ﹤0.01% 4736
2022
Q2 		$10K Buy
8,302
+1,504
+22% +$2.04K ﹤0.01% 4514
2022
Q1 		$12K Sell
6,798
-5,136
-43% -$14.4K ﹤0.01% 4123
2021
Q4 		$63K Buy
11,934
+2,949
+33% +$22.8K ﹤0.01% 2587
2021
Q3 		$84K Buy
8,985
+6,906
+332% +$78.8K ﹤0.01% 2543
2021
Q2 		$29K Buy
2,079
+987
+90% +$15.2K ﹤0.01% 3548
2021
Q1 		$15K Buy
1,092
+933
+587% +$19.3K ﹤0.01% 4133
2020
Q4 		$5K Buy
+159
New +$3.68K ﹤0.01% 4662

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $328M AUM 19.81% 1-Year Est. Return